Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Bone Marrow Versus Mobilized Peripheral Blood Stem Cells for Non T Depleted Haploidentical Transplantations with Post Transplantation Cyclophosphamide in Acute Lymphoblastic Leukemia: On Behalf of the ALWP of the EBMT

Arnon Nagler, MD MSc, Myriam Labopin, MD, Emanuele Angelucci, MD, Yener Koc, MD, Mutlu Arat, MD, Pietro Pioltelli, MD, Simona Sica, MD, Zafer Gülbas, MD, Johanna Tischer, MD, Paolo Bernasconi, MD, Jiri Pavlu, MDMRCP,FRCPath, Gerard Socie, MD PhD, Didier Blaise, MD PhD, Luigi Rigacci, MD, Massimo Martino, MD, José Luis Díez-Martín, MD PhD, Zinaida Peric, MD PhD, Sebastian Giebel, MD PhD, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 589.

https://doi.org/10.1182/blood-2019-121644

Published: 2019

Journal Articles

Basal CD34+ Cell Count Predicts Peripheral Blood Hematopoietic Progenitor Cells Mobilization in Healthy Donors after Administration of G-CSF

Massimo Martino, MD, Mercedes Gori, Annalisa Pitino, Antonella Dattola, Roberta Fedele, MD, Giuseppe Alberto Gallo, Santina Barillà, Antonella Pontari, Giuseppe Irrera, MD, Giuseppe Messina, MD, Tiziana Moscato, Giuseppe Console, MD, Fortunato Morabito, Giovanni Tripepi

Blood (2016) 128 (22): 3380.

https://doi.org/10.1182/blood.V128.22.3380.3380

Published: 2016

Journal Articles

A Phase 2 Study of Bendamustine Plus Melphalan Conditioning for Second Autologous Stem Cell Transplantation in "De-Novo" Multiple Myeloma Patients in a Tandem Transplant Strategy

Massimo Martino, MD, Messina Giuseppe, MD, Roberta Fedele, MD, Giuseppe Irrera, MD, Console Giuseppe, MD, Giuseppe Alberto Gallo, Iolanda Donatella Vincelli, Francesca Ronco, Massimo Gentile, MD, Fortunato Morabito, MD

Blood (2015) 126 (23): 3197.

https://doi.org/10.1182/blood.V126.23.3197.3197

Published: 2015

Journal Articles

Bendamustine Plus Melphalan As Conditioning Regimen for Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Single Centre Experience

Massimo Martino, MD, Giuseppe Messina, MD, Tiziana Moscato, MD, Roberta Fedele, MD, Giuseppe Console, MD, Giuseppe Console, MD, Iolanda Donatella Vincelli, MD, Francesca Ronco, MD, Giuseppe Irrera, MD

Blood (2014) 124 (21): 2516.

https://doi.org/10.1182/blood.V124.21.2516.2516

Published: 2014

Journal Articles

Biosimilar Compared with Originator Filgrastim for Autologous Stems CELL Mobilisation: A Prospective-Historical Control Study in Multiple Myeloma REAL-Life Setting

Massimo Martino, MD, Tiziana Moscato, MD, Iolanda Donatella Vincelli, MD, Francesca Ronco, Roberta Fedele, MD, Giuseppe Irrera, MD, Giuseppe Console, MD, Giuseppe Messina, MD, Eugenio Piro, MD, Stefano Molica, MD, Fortunato Morabito, MD

Blood (2014) 124 (21): 5825.

https://doi.org/10.1182/blood.V124.21.5825.5825

Published: 2014

Journal Articles

Homozygosity for Killer Immunoglobin-like Receptor (KIR) Haplotype a Is Associated to Negative Interim Positron Emission Tomography (PET) and a Favourable Outcome in Hodgkin Lymphoma

Giovanni Caocci, MD, Roberto Littera, MD, Sara Oppi, MD, Marianna Greco, PhD, Ivana Celeghini, MD, Rossella Caria, MD, Sara Lai, Dr., Nicola Orrù, Dr., Massimo Martino, MD, Carlo Carcassi, MD, Andrea Gallamini, MD, Giorgio La Nasa, MD

Blood (2014) 124 (21): 133.

https://doi.org/10.1182/blood.V124.21.133.133

Published: 2014

Journal Articles

Safety of Peripheral Hematopoietic Stem Cell Mobilization with Lenograstim in Allogeneic Healthy Donors ≥ 50 Years Old: A Single-Centre Experience

Massimo Martino, MD, Antonella Dattola, Roberta Fedele, MD, Antonella Pontari, Tiziana Moscato, MD, Maria Cuzzola, Tiziana Martinello

Blood (2014) 124 (21): 3844.

https://doi.org/10.1182/blood.V124.21.3844.3844

Published: 2014

Journal Articles

Plerixafor On Demand Associated With Chemotherapy and G-CSF: Interim Analysis Of a Prospective Study Shows Significant Improvement In PBSC Mobilization and Harvest With No Increase In Costs

Giuseppe Milone, MD, Massimo Martino, MD, Potito R Scalzulli, M.D., Andrea Spadaro, MD, Valentina Di Martina, MD, Elena Schinocca, MD, Eleonora Spina, MD, Annalia Di Marco, BS, Alessandra Cupri, Giovanni Tripepi, MD, Salvatore Leotta, MD

Blood (2013) 122 (21): 4509.

https://doi.org/10.1182/blood.V122.21.4509.4509

Published: 2013

Journal Articles

At-Home Management of Aplastic Phase Following High-Dose Melphalan and Autologous Haematopoietic Stem Cell Transplantation for Multiple Myeloma Patients: A Pilot Study

Massimo Martino, MD, Grazia Pellicano’, MD, Tiziana Moscato, MD, Elisabetta Massara, MD, Roberta Fedele, MD, Giuseppe Console, MD, Letteria Russo, Miss, Giuseppe Messina, MD, Rosalba Di Filippo Scali, Giuseppe Irrera, MD

Blood (2011) 118 (21): 4497.

https://doi.org/10.1182/blood.V118.21.4497.4497

Published: 2011

Journal Articles

Is Antifungal Prophylaxis Useful In Stem Cell Transplantation (SCT) During Hospitalization?.

Giuseppe Irrera, MD, Messina Giuseppe, MD, Giuseppe Console, MD, Massimo Martino, MD, Cuzzola Maria, Antonella Meliadò, Pasquale Iacopino

Blood (2010) 116 (21): 4541.

https://doi.org/10.1182/blood.V116.21.4541.4541

Published: 2010

Journal Articles

Mobilizing Chemotherapy Followed by G-CSF, Additioned by Plerixafor on Demand, Is Safe and Allows Both Adequate PBSC (Peripheral Blood Stem Cell) Collection and Safe ASCT (Autologous Stem Cell Transplantation) In Multiple Myeloma and Lymphoma Patients

Immacolata Attolico, Vincenzo Pavone, MD, MD, CH, Angelo Ostuni, Maurizio Musso, Alessandra Crescimanno, Massimo Martino, MD, Pasquale Iacopino, Giuseppe Milone, MD, Patrizia Tedeschi, Attilio Olivieri

Blood (2010) 116 (21): 2257.

https://doi.org/10.1182/blood.V116.21.2257.2257

Published: 2010

NARROW

Bone Marrow Versus Mobilized Peripheral Blood Stem Cells for Non T Depleted Haploidentical Transplantations with Post Transplantation Cyclophosphamide in Acute Lymphoblastic Leukemia: On Behalf of the ALWP of the EBMT

Basal CD34+ Cell Count Predicts Peripheral Blood Hematopoietic Progenitor Cells Mobilization in Healthy Donors after Administration of G-CSF

A Phase 2 Study of Bendamustine Plus Melphalan Conditioning for Second Autologous Stem Cell Transplantation in "De-Novo" Multiple Myeloma Patients in a Tandem Transplant Strategy

Bendamustine Plus Melphalan As Conditioning Regimen for Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Single Centre Experience

Biosimilar Compared with Originator Filgrastim for Autologous Stems CELL Mobilisation: A Prospective-Historical Control Study in Multiple Myeloma REAL-Life Setting

Homozygosity for Killer Immunoglobin-like Receptor (KIR) Haplotype a Is Associated to Negative Interim Positron Emission Tomography (PET) and a Favourable Outcome in Hodgkin Lymphoma

Safety of Peripheral Hematopoietic Stem Cell Mobilization with Lenograstim in Allogeneic Healthy Donors ≥ 50 Years Old: A Single-Centre Experience

Plerixafor On Demand Associated With Chemotherapy and G-CSF: Interim Analysis Of a Prospective Study Shows Significant Improvement In PBSC Mobilization and Harvest With No Increase In Costs

At-Home Management of Aplastic Phase Following High-Dose Melphalan and Autologous Haematopoietic Stem Cell Transplantation for Multiple Myeloma Patients: A Pilot Study

Is Antifungal Prophylaxis Useful In Stem Cell Transplantation (SCT) During Hospitalization?.

Mobilizing Chemotherapy Followed by G-CSF, Additioned by Plerixafor on Demand, Is Safe and Allows Both Adequate PBSC (Peripheral Blood Stem Cell) Collection and Safe ASCT (Autologous Stem Cell Transplantation) In Multiple Myeloma and Lymphoma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only